Therapeutic drug monitoring is the measurement of specific drugs at timed intervals in order to maintain a relatively constant concentration of the medication in the blood. Monitored drugs tend to have a narrow "therapeutic index," – the difference between the toxic and therapeutic doses of medications. For some drugs, maintaining this steady concentration in the blood is not as simple as giving a standard dose of medication to everyone. Each person will absorb, metabolise, utilise, and eliminate drugs at different rates based upon their age, general state of health, genetic makeup, and the influence of other medications that they are taking. These factors may change over time and vary from day to day or with various disease states.

Market Analysis and Insights: Global Theraputic Drug Monitorings Market
The global Theraputic Drug Monitorings market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Theraputic Drug Monitorings market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Theraputic Drug Monitorings market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Theraputic Drug Monitorings market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Theraputic Drug Monitorings market.

Global Theraputic Drug Monitorings Scope and Market Size
Theraputic Drug Monitorings market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Theraputic Drug Monitorings market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemiluminescence Immunoassay (CLIA)
Fluorescence Immunoassay (FPIA)
Radioimmunoassay (RIA)
Colorimetric Immunoassay
Other Immunoassays

Segment by Application
Antiepileptic Drugs
Immunosuppressant
Antitumor Drugs
Psychotropic Drugs
Antibiotic
Antifungal
Cardiovascular Drugs
Antiasthmatic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche AG
Siemens Healthineers
Thermo Fisher Scientific
Beckman Coulter
Agilent Technologies
BioMérieux
Sekisui Medical
DiaSorin
Fujirebio
Grifols
Ortho-Clinical Diagnostics
Quest Diagnostics
Sysmex
Tosoh
Chromsystems
Bio-Rad
R-Biopharm AG
ALPCO
BIOHIT Healthcare
MedTox
Wieslab
ARK Diagnostics
Probe Scientific
Omnica